Dynamic Myocardial Perfusion CT for the Detection of Hemodynamically Significant Coronary Artery Disease

Fay M.A. Nous, Tobias Geisler, Mariusz B.P. Kruk, Hatem Alkadhi, Kakuya Kitagawa, Rozemarijn Vliegenthart, Michaela M. Hell, Jörg Hausleiter, Patricia K. Nguyen, Ricardo P.J. Budde, Konstantin Nikolaou, Cezary Kepka, Robert Manka, Hajime Sakuma, Sachin B. Malik, Adriaan Coenen, Felix Zijlstra, Ernst Klotz, Pim van der Harst, Christoph ArtznerAdmir Dedic, Francesca Pugliese, Fabian Bamberg, Koen Nieman*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Scopus)
10 Downloads (Pure)

Abstract

Objectives: In this international, multicenter study, using third-generation dual-source computed tomography (CT), we investigated the diagnostic performance of dynamic stress CT myocardial perfusion imaging (CT-MPI) in addition to coronary CT angiography (CTA) compared to invasive coronary angiography (ICA) and invasive fractional flow reserve (FFR). Background: CT-MPI combined with coronary CTA integrates coronary artery anatomy with inducible myocardial ischemia, showing promising results for the diagnosis of hemodynamically significant coronary artery disease in single-center studies. Methods: At 9 centers in Europe, Japan, and the United States, 132 patients scheduled for ICA were enrolled; 114 patients successfully completed coronary CTA, adenosine-stress dynamic CT-MPI, and ICA. Invasive FFR was performed in vessels with 25% to 90% stenosis. Data were analyzed by independent core laboratories. For the primary analysis, for each coronary artery the presence of hemodynamically significant obstruction was interpreted by coronary CTA with CT-MPI compared to coronary CTA alone, using an FFR of ≤0.80 and angiographic severity as reference. Territorial absolute myocardial blood flow (MBF) and relative MBF were compared using C-statistics. Results: ICA and FFR identified hemodynamically significant stenoses in 74 of 289 coronary vessels (26%). Coronary CTA with ≥50% stenosis demonstrated a per-vessel sensitivity, specificity, and accuracy for the detection of hemodynamically significant stenosis of 96% (95% CI: 91%-100%), 72% (95% CI: 66%-78%), and 78% (95% CI: 73%-83%), respectively. Coronary CTA with CT-MPI showed a lower sensitivity (84%; 95% CI: 75%-92%) but higher specificity (89%; 95% CI: 85%-93%) and accuracy (88%; 95% CI: 84%-92%). The areas under the receiver-operating characteristic curve of absolute MBF and relative MBF were 0.79 (95% CI: 0.71-0.86) and 0.82 (95% CI: 0.74-0.88), respectively. The median dose-length product of CT-MPI and coronary CTA were 313 mGy·cm and 138 mGy·cm, respectively. Conclusions: Dynamic CT-MPI offers incremental diagnostic value over coronary CTA alone for the identification of hemodynamically significant coronary artery disease. Generalized results from this multicenter study encourage broader consideration of dynamic CT-MPI in clinical practice. (Dynamic Stress Perfusion CT for Detection of Inducible Myocardial Ischemia [SPECIFIC]; NCT02810795)

Original languageEnglish
Pages (from-to)75-87
Number of pages13
JournalJACC: Cardiovascular Imaging
Volume15
Issue number1
DOIs
Publication statusPublished - 1 Jan 2022

Bibliographical note

Funding Information:
This study was supported by unrestricted grants from Siemens Healthineers and Bayer Healthcare. Dr Nguyen’s research is supported by the National Institutes of Health (R01HL134830-01). Koen Nieman’s research is supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health (R01HL141712; R01HL146754). Dr Geisler has received research grants from Medtronic and Edwards Lifesciences. Dr Kitagawa has received an endowed chair position supported by Siemens Healthineers. Dr Vliegenthart has received an institutional research grant from Siemens Healthineers. Dr Hausleiter has received receiving speaker honoraria and research support from Abbott Vascular and Edwards Lifesciences; and has served as a consultant for Edwards Lifesciences. Dr Pugliese has received research support from Siemens Healthineers. Dr Budde has received institutional research support to the Erasmus MC from Siemens Healthineers. Dr Nikolauo has received research grants from Siemens Healthineers, GE Healthcare, and Bayer Healthcare; and has served as a consultant for Siemens Healthineers; and Bayer Healthcare. Dr Sakuma has received departmental research grants from FUJIFILM Toyama Chemical Co, Ltd, and Guerbet Japan KK. Dr Klotz is a retired employee of and serves as a consultant for Siemens Healthineers. Dr Bamberg has received research grants from Siemens Healthineers and Bayer Healthcare; and has served as a consultant for Siemens Healthineers, Bayer Healthcare, and Bracco. Dr Nieman has received unrestricted institutional research support from Siemens Healthineers and HeartFlow Inc; has served as a consultant for Siemens Medical Systems USA; and holds equity in Lumen Therapeutics. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Publisher Copyright:
© 2022 The Authors

Fingerprint

Dive into the research topics of 'Dynamic Myocardial Perfusion CT for the Detection of Hemodynamically Significant Coronary Artery Disease'. Together they form a unique fingerprint.

Cite this